Trial Profile
Open-label, Randomized Comparative Study to Evaluate the Pharmacokinetic Characteristics of Fenofibric Acid Between Lipidilsupra Tablet and HIP0901 Capsule in Healthy Male Subjects.
Status:
Active, no longer recruiting
Phase of Trial:
Phase I
Latest Information Update: 18 Sep 2019
Price :
$35
*
At a glance
- Drugs Fenofibric-acid (Primary)
- Indications Hyperlipidaemia
- Focus Pharmacokinetics
- Sponsors Hanmi Pharmaceutical
- 15 Feb 2012 New source identified and integrated (Clinical Research Information Service (CriS) - Republic of Korea)
- 17 Jan 2012 New trial record